February 15, 2026 - 19:12

GE HealthCare Technologies Inc. has solidified its commitment to shareholder returns with the declaration of its latest quarterly cash dividend. The company's board authorized a payment of $0.035 per share, scheduled for distribution in mid-May of 2026 to investors on record in early April.
This move underscores the firm's financial stability and disciplined capital allocation strategy following its spin-off from General Electric. As a standalone entity, GE HealthCare has focused on advancing its comprehensive portfolio of medical technology, which includes imaging equipment, patient monitoring systems, and digital solutions aimed at improving hospital efficiency and patient outcomes.
The company's consistent performance and strategic investments in innovation have reinforced its reputation as a leading player in the global healthcare technology sector. By integrating advanced artificial intelligence and data analytics into its devices and software platforms, GE HealthCare aims to address some of the most pressing challenges in modern medicine, from streamlining clinical workflows to enabling more precise diagnostics.
Industry analysts view the reliable dividend declaration as a positive indicator of the company's ongoing operational strength and future growth prospects within the evolving digital healthcare landscape. The announcement reflects confidence in sustained cash flow generation, which supports both shareholder returns and continued research and development initiatives.
May 16, 2026 - 17:43
From Biobank to Breakthrough: Activating Proteomic Data for Precision MedicineA new webinar is set to examine how scientists can better tap into the massive amounts of proteomic data already sitting in biobanks and population studies. The session, which draws on real-world...
May 16, 2026 - 02:18
Testing new technology is one thing, making it work in the field and getting people to trust and use it is anotherThe pace of technological innovation has been staggering over the past few years, but according to industry expert Scott Hutchins, the hardest part isn`t the invention itself. It is getting people...
May 15, 2026 - 07:50
Sharps Technology Adopts Limited Duration Stockholder Rights PlanSharps Technology, Inc., a medical device company specializing in safety syringes and related products, announced that its Board of Directors has approved and adopted a limited-duration stockholder...
May 14, 2026 - 22:19
Disguise and Creative Technology Bring Next-Gen Visuals to Eurovision for Eighth YearLONDON -- Disguise has once again teamed up with Creative Technology to power the visual production of the Eurovision Song Contest, marking the eighth consecutive year the two companies have...